Log in
Enquire now

List of Caregen Co., Ltd. patents

List of Caregen Co., Ltd. patents
List of Samsonite patents
List of Imperial Innovations patents
List of Phynexus, Inc. patents
List of SBIR/STTR awards granted to SYNERGENE THERAPEUTICS INC
List of Techstars Class 65 - Barclays 2016 Winter companies
Patents where
Current Assignee
Name
is
Caregen Co., Ltd.Caregen Co., Ltd.
Name
Description
Patent Applicant
Current Assignee
Inventor
Patent Jurisdiction
Patent Number
Date of Patent
‌
US Patent 11512112 Peptide for suppressing osteoclast differentiation and use thereof

Patent 11512112 was granted and assigned to Caregen Co., Ltd. on November, 2022 by the United States Patent and Trademark Office.

Caregen Co., Ltd.
Caregen Co., Ltd.
Caregen Co., Ltd.
Caregen Co., Ltd.
United States Patent and Trademark Office
United States Patent and Trademark Office
11512112
November 29, 2022
‌
US Patent 11433013 Peptide for preventing skin damage caused by air pollutants and for anti-aging, and use thereof

Patent 11433013 was granted and assigned to Caregen Co., Ltd. on September, 2022 by the United States Patent and Trademark Office.

Caregen Co., Ltd.
Caregen Co., Ltd.
Caregen Co., Ltd.
Caregen Co., Ltd.
United States Patent and Trademark Office
United States Patent and Trademark Office
11433013
September 6, 2022
‌
US Patent 11357783 Conjugate of finasteride with peptide

Patent 11357783 was granted and assigned to Caregen Co., Ltd. on June, 2022 by the United States Patent and Trademark Office.

Caregen Co., Ltd.
Caregen Co., Ltd.
Caregen Co., Ltd.
Caregen Co., Ltd.
United States Patent and Trademark Office
United States Patent and Trademark Office
11357783
June 14, 2022
‌
US Patent 11597748 Peptide having cytoprotective effect against environmental pollutant and use thereof

Patent 11597748 was granted and assigned to Caregen Co., Ltd. on March, 2023 by the United States Patent and Trademark Office.

Caregen Co., Ltd.
Caregen Co., Ltd.
Caregen Co., Ltd.
Caregen Co., Ltd.
United States Patent and Trademark Office
United States Patent and Trademark Office
11597748
March 7, 2023
‌
US Patent 11518785 Peptide showing melanogenesis promoting activity and use thereof

Caregen Co., Ltd.
Caregen Co., Ltd.
Caregen Co., Ltd.
Caregen Co., Ltd.
United States Patent and Trademark Office
United States Patent and Trademark Office
11518785
December 6, 2022
‌
US Patent 11617796 Conjugate of minoxidil and peptide

Patent 11617796 was granted and assigned to Caregen Co., Ltd. on April, 2023 by the United States Patent and Trademark Office.

Caregen Co., Ltd.
Caregen Co., Ltd.
Caregen Co., Ltd.
Caregen Co., Ltd.
United States Patent and Trademark Office
United States Patent and Trademark Office
11617796
April 4, 2023
‌
US Patent 11351266 Conjugate of isotretinoin and peptide

Patent 11351266 was granted and assigned to Caregen Co., Ltd. on June, 2022 by the United States Patent and Trademark Office.

Caregen Co., Ltd.
Caregen Co., Ltd.
Caregen Co., Ltd.
Caregen Co., Ltd.
United States Patent and Trademark Office
United States Patent and Trademark Office
11351266
June 7, 2022
‌
US Patent 11104704 Peptide having cytoprotective effect against environmental pollutant and use thereof

Patent 11104704 was granted and assigned to Caregen Co., Ltd. on August, 2021 by the United States Patent and Trademark Office.

Caregen Co., Ltd.
Caregen Co., Ltd.
Caregen Co., Ltd.
Caregen Co., Ltd.
United States Patent and Trademark Office
United States Patent and Trademark Office
11104704
August 31, 2021
‌
US Patent 10047125 Peptide having activity to improve skin condition and use thereof

Patent 10047125 was granted and assigned to Caregen Co., Ltd. on August, 2018 by the United States Patent and Trademark Office.

Caregen Co., Ltd.
Caregen Co., Ltd.
Caregen Co., Ltd.
Caregen Co., Ltd.
United States Patent and Trademark Office
United States Patent and Trademark Office
10047125
August 14, 2018
‌
US Patent 8691195 Peptide having activity of transforming growth factor and production method therefor

Patent 8691195 was granted and assigned to Caregen Co., Ltd. on April, 2014 by the United States Patent and Trademark Office.

Caregen Co., Ltd.
Caregen Co., Ltd.
United States Patent and Trademark Office
United States Patent and Trademark Office
8691195
April 8, 2014
‌
US Patent 11306121 Composition for muscle relaxation

Patent 11306121 was granted and assigned to Caregen Co., Ltd. on April, 2022 by the United States Patent and Trademark Office.

Caregen Co., Ltd.
Caregen Co., Ltd.
Caregen Co., Ltd.
Caregen Co., Ltd.
United States Patent and Trademark Office
United States Patent and Trademark Office
11306121
April 19, 2022
‌
US Patent 11103436 Peptide exhibiting wrinkle-improving activity and uses thereof

Patent 11103436 was granted and assigned to Caregen Co., Ltd. on August, 2021 by the United States Patent and Trademark Office.

Caregen Co., Ltd.
Caregen Co., Ltd.
Caregen Co., Ltd.
Caregen Co., Ltd.
United States Patent and Trademark Office
United States Patent and Trademark Office
11103436
August 31, 2021
‌
US Patent 8729028 Noggin-derived peptide and use thereof

Patent 8729028 was granted and assigned to Caregen Co., Ltd. on May, 2014 by the United States Patent and Trademark Office.

Caregen Co., Ltd.
Caregen Co., Ltd.
United States Patent and Trademark Office
United States Patent and Trademark Office
8729028
May 20, 2014
‌
US Patent 8969296 TGFP-CAP peptide and its uses

Patent 8969296 was granted and assigned to Caregen Co., Ltd. on March, 2015 by the United States Patent and Trademark Office.

Caregen Co., Ltd.
Caregen Co., Ltd.
United States Patent and Trademark Office
United States Patent and Trademark Office
8969296
March 3, 2015
‌
US Patent 10093698 Peptide having efficacy for remedying hypopigmentation and inhibiting adipogenesis, and use of same

Patent 10093698 was granted and assigned to Caregen Co., Ltd. on October, 2018 by the United States Patent and Trademark Office.

Caregen Co., Ltd.
Caregen Co., Ltd.
Caregen Co., Ltd.
Caregen Co., Ltd.
United States Patent and Trademark Office
United States Patent and Trademark Office
10093698
October 9, 2018
‌
US Patent 9637519 Peptide for inducing mast cell-specific apoptosis and use thereof

Patent 9637519 was granted and assigned to Caregen Co., Ltd. on May, 2017 by the United States Patent and Trademark Office.

Caregen Co., Ltd.
Caregen Co., Ltd.
Caregen Co., Ltd.
Caregen Co., Ltd.
United States Patent and Trademark Office
United States Patent and Trademark Office
9637519
May 2, 2017
‌
US Patent 9908916 Peptide for suppressing osteoclast differentiation and use thereof

Patent 9908916 was granted and assigned to Caregen Co., Ltd. on March, 2018 by the United States Patent and Trademark Office.

Caregen Co., Ltd.
Caregen Co., Ltd.
Caregen Co., Ltd.
Caregen Co., Ltd.
United States Patent and Trademark Office
United States Patent and Trademark Office
9908916
March 6, 2018
‌
US Patent 10526373 Peptide showing melanin generation-promoting activity and use thereof

Patent 10526373 was granted and assigned to Caregen Co., Ltd. on January, 2020 by the United States Patent and Trademark Office.

Caregen Co., Ltd.
Caregen Co., Ltd.
Caregen Co., Ltd.
Caregen Co., Ltd.
United States Patent and Trademark Office
United States Patent and Trademark Office
10526373
January 7, 2020
‌
US Patent 8188049 Peptides having activities of epidermal growth factor and its uses

Patent 8188049 was granted and assigned to Caregen Co., Ltd. on May, 2012 by the United States Patent and Trademark Office.

Caregen Co., Ltd.
Caregen Co., Ltd.
United States Patent and Trademark Office
United States Patent and Trademark Office
8188049
May 29, 2012
‌
US Patent 10238710 Peptide having anti-inflammatory, osteogenic and hair growth promoting activities, and use of same

Patent 10238710 was granted and assigned to Caregen Co., Ltd. on March, 2019 by the United States Patent and Trademark Office.

Caregen Co., Ltd.
Caregen Co., Ltd.
Caregen Co., Ltd.
Caregen Co., Ltd.
United States Patent and Trademark Office
United States Patent and Trademark Office
10238710
March 26, 2019
‌
US Patent 10080775 Peptide having skin whitening activity, and use thereof

Patent 10080775 was granted and assigned to Caregen Co., Ltd. on September, 2018 by the United States Patent and Trademark Office.

Caregen Co., Ltd.
Caregen Co., Ltd.
Caregen Co., Ltd.
Caregen Co., Ltd.
United States Patent and Trademark Office
United States Patent and Trademark Office
10080775
September 25, 2018
‌
US Patent 11072636 Peptide for inhibiting angiogenesis and use thereof

Patent 11072636 was granted and assigned to Caregen Co., Ltd. on July, 2021 by the United States Patent and Trademark Office.

Caregen Co., Ltd.
Caregen Co., Ltd.
Caregen Co., Ltd.
Caregen Co., Ltd.
United States Patent and Trademark Office
United States Patent and Trademark Office
11072636
July 27, 2021
‌
US Patent 11179435 Hangover alleviating composition containing conjugate of sesamol and peptide as active ingredient

Patent 11179435 was granted and assigned to Caregen Co., Ltd. on November, 2021 by the United States Patent and Trademark Office.

Caregen Co., Ltd.
Caregen Co., Ltd.
Caregen Co., Ltd.
Caregen Co., Ltd.
United States Patent and Trademark Office
United States Patent and Trademark Office
11179435
November 23, 2021
‌
US Patent 10865226 Peptide showing melanogenesis promoting activity and use thereof

Caregen Co., Ltd.
Caregen Co., Ltd.
Caregen Co., Ltd.
Caregen Co., Ltd.
United States Patent and Trademark Office
United States Patent and Trademark Office
10865226
December 15, 2020
‌
US Patent 11253604 Conjugate of methotrexate and peptide

Patent 11253604 was granted and assigned to Caregen Co., Ltd. on February, 2022 by the United States Patent and Trademark Office.

Caregen Co., Ltd.
Caregen Co., Ltd.
Caregen Co., Ltd.
Caregen Co., Ltd.
United States Patent and Trademark Office
United States Patent and Trademark Office
11253604
February 22, 2022
Results per page:
53 results
0 selected
53 results
0 selected
Golden logo

Company

  • Home
  • Pricing
  • Become an Editor
  • Enterprise

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us

Explore companies

  • Artificial Intelligence
  • Fintech
  • Biotechnology
  • Cybersecurity
  • Semiconductors
  • Electric Vehicles
  • Cloud Computing
  • Robotics
  • SaaS
  • Renewable Energy
  • Venture Capital
  • Blockchain
  • Browse all →